7Baggers
 published on: 2025-09-18 13:32:09  newser.com Thu, 18 Sep 2025 18:32:09 GMT

IN8bio, Inc.
(NASDAQ:INAB) 

INAB stock logo

IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. The company develops INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I cli...

Founded: 2016
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends